Search research articles
Contact Us
Filters
Showing results (201-210 of 209) with videos related to
Page
of 21
Sort By:
You have reached the last page of results.
This site can display upto 209 results.
Journal of Medicinal Chemistry
|
June 25, 2024
2,8-Disubstituted-1,5-naphthyridines as Dual Inhibitors of <i>Plasmodium falciparum</i> Phosphatidylinositol-4-kinase and Hemozoin Formation with <i>In Vivo</i> Efficacy
Godwin Akpeko Dziwornu, Donald Seanego, Stephen Fienberg, et al.
Nature Communications
|
May 13, 2021
Author Correction: Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
Xin Hu, Junya Fujimoto, Lisha Ying, et al.
Nature Communications
|
July 7, 2019
Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
Xin Hu, Junya Fujimoto, Lisha Ying, et al.
JACC. Advances
|
June 28, 2024
Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19
Lucas C Godoy, Matthew D Neal, Ewan C Goligher, et al.
Research Square
|
August 7, 2023
Reaction hijacking inhibition of <i>Plasmodium falciparum</i> asparagine tRNA synthetase
Stanley C Xie, Yinuo Wang, Craig J Morton, et al.
Nature Communications
|
January 31, 2024
Reaction hijacking inhibition of Plasmodium falciparum asparagine tRNA synthetase
Stanley C Xie, Yinuo Wang, Craig J Morton, et al.
JAMA
|
April 11, 2023
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial
, Patrick R Lawler, Lennie P G Derde, et al.
The New England Journal of Medicine
|
August 5, 2021
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
, , , et al.
The New England Journal of Medicine
|
August 5, 2021
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
, , , et al.
Page
of 21
Search research articles
Search
Showing results (201-210 of 209) with videos related to
Sort By:
Page
of 21
You have reached the last page of results.
This site can display upto 209 results.
Journal of Medicinal Chemistry
|
June 25, 2024
2,8-Disubstituted-1,5-naphthyridines as Dual Inhibitors of <i>Plasmodium falciparum</i> Phosphatidylinositol-4-kinase and Hemozoin Formation with <i>In Vivo</i> Efficacy
Godwin Akpeko Dziwornu, Donald Seanego, Stephen Fienberg, et al.
Nature Communications
|
May 13, 2021
Author Correction: Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
Xin Hu, Junya Fujimoto, Lisha Ying, et al.
Nature Communications
|
July 7, 2019
Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
Xin Hu, Junya Fujimoto, Lisha Ying, et al.
JACC. Advances
|
June 28, 2024
Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19
Lucas C Godoy, Matthew D Neal, Ewan C Goligher, et al.
Research Square
|
August 7, 2023
Reaction hijacking inhibition of <i>Plasmodium falciparum</i> asparagine tRNA synthetase
Stanley C Xie, Yinuo Wang, Craig J Morton, et al.
Nature Communications
|
January 31, 2024
Reaction hijacking inhibition of Plasmodium falciparum asparagine tRNA synthetase
Stanley C Xie, Yinuo Wang, Craig J Morton, et al.
JAMA
|
April 11, 2023
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial
, Patrick R Lawler, Lennie P G Derde, et al.
The New England Journal of Medicine
|
August 5, 2021
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
, , , et al.
The New England Journal of Medicine
|
August 5, 2021
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
, , , et al.
Page
of 21